Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with β-phenylethyl isothiocyanate and curcumin

Carcinogenesis

Volumn 27, Issue 3, 2006, Pages 475-482

  Kim, Jung Hwan ^a   Xu, Changjiang ^a   Keum, Young Sam ^a   Reddy, Bandaru ^a   Conney, Allan ^a   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CURCUMIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHENETHYL ISOTHIOCYANATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; THREONINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CURCUMIN; DRUG INTERACTIONS; HUMANS; ISOTHIOCYANATES; LUCIFERASES; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 33644869673     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi272     Document Type: Article

References (26)

1. Landis, S.H., Murray, T., Bolden, S. and Wingo, P.A. (1999) Cancer statistics, 1999. CA Cancer J. Clin., 49, 8-31, 1.
2. Kreis,W. (1995) Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Invest., 13, 296-312.
3. Sherwood,E.R., Van Dongen,J.L., Wood,C.G., Liao,S., Kozlowski,J.M. and Lee,C. (1998) Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells. Br. J. Cancer, 77, 855-861.
4. Davies,P., Eaton,C.L., France,T.D. and Phillips,M.E. (1988) Growth factor receptors and oncogene expression in prostate cells. Am. J. Clin. Oncol., 11 (suppl. 2), S1-7.
5. Festuccia,C., Gravina,G.L., Angelucci,A., Millimaggi,D., Muzi,P., Vicentini,C. and Bologna,M. (2005) Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro. Int. J. Cancer, 115, 630-640.
6. Chiao,J.W., Chung,F.L., Kancherla,R., Ahmed,T., Mittelman,A. and Conaway,C.C. (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 20, 631-636.
7. Dorai,T., Gehani,N. and Katz,A. (2000) Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol. Urol., 4, 1-6.
8. Xiao,D. and Singh,S.V. (2002) Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res., 62, 3615-3619.
9. Xu,C., Shen,G., Chen,C., Gelinas,C. and Kong,A.N. (2005) Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells. Oncogene, 24, 4486-95.
10. Cohen,J.H., Kristal,A.R. and Stanford,J.L. (2000) Fruit and vegetable intakes and prostate cancer risk. J. Natl Cancer Inst., 92, 61-8.
11. Kolonel,L.N., Hankin,J.H., Whittemore,A.S. et al. (2000) Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev., 9, 795-804.
12. Reddy,B.S., Nayini,J., Tokumo,K., Rigotty,J., Zang,E. and Kelloff,G. (1990) Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res., 50, 2562-2568.
13. Saeki,K., Kobayashi,N., Inazawa,Y., Zhang,H., Nishitoh,H., Ichijo,H., Saeki,K., Isemura,M. and Yuo,A. (2002) Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): A distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem. J., 368, 705-720.
14. Chen,D., Xu,L.G., Chen,L., Li,L., Zhai,Z. and Shu,H.B. (2003) NIK is a component of the EGF/heregulin receptor signaling complexes. Oncogene, 22, 4348-4355.
15. Habib,A.A., Chatterjee,S., Park,S.K., Ratan,R.R., Lefebvre,S. and Vartanian,T. (2001) The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome. J. Biol. Chem., 276, 8865-8874.
16. Dorai,T., Dutcher,J.P., Dempster,D.W. and Wiernik,P.H. (2004) Therapeutic potential of curcumin in prostate cancer-V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate, 60, 1-17.
17. Mukhopadhyay,A., Bueso-Ramos,C., Chatterjee,D., Pantazis,P. and Aggarwal,B.B. (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene, 20, 7597-7609.
18. Huang,S.M., Li,J. and Harari,P.M. (2002) Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Mol. Cancer Ther., 1, 507-514.
19. Chott,A., Sun,Z., Morganstern,D., Pan,J., Li,T., Susani,M., Mosberger,I., Upton,M.P., Bubley,G.J. and Balk,S.P. (1999) Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am. J. Pathol., 155, 1271-1279.
20. Suh,J., Payvandi,F., Edelstein,L.C., Amenta,P.S., Zong,W.X., Gelinas,C. and Rabson,A.B. (2002) Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate, 52, 183-200.
21. Datta,S.R., Brunet,A. and Greenberg,M.E. (1999) Cellular survival: A play in three Akts. Genes Dev., 13, 2905-2927.
22. Hill,M.M. and Hemmings,B.A. (2002) Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol. Ther., 93, 243-251.
23. Teng,D.H., Hu,R., Lin,H. et al. (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57, 5221-5225.
24. Leu,T.H., Su,S.L., Chuang,Y.C. and Maa,M.C. (2003) Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem. Pharmacol., 66, 2323-2331.
25. Chen,Y.R., Han,J., Kori,R., Kong,A.N. and Tan,T.H. (2002) Phenylethyl isothiocyanate induces apoptotic signaling via suppressing phosphatase activity against c-Jun N-terminal kinase. J. Biol. Chem., 277, 39334-39342.
26. Myzak, M.C., Karplus, P.A., Chung, F.L. and Dashwood, R.H. (2004) A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase. Cancer Res., 64, 5767-5774.